355 related articles for article (PubMed ID: 29877755)
1. Combatting resistant enterococcal infections: a pharmacotherapy review.
Mercuro NJ; Davis SL; Zervos MJ; Herc ES
Expert Opin Pharmacother; 2018 Jun; 19(9):979-992. PubMed ID: 29877755
[TBL] [Abstract][Full Text] [Related]
2. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin-resistant enterococcal urinary tract infections.
Heintz BH; Halilovic J; Christensen CL
Pharmacotherapy; 2010 Nov; 30(11):1136-49. PubMed ID: 20973687
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant enterococcal bacteremia pharmacotherapy.
Patel R; Gallagher JC
Ann Pharmacother; 2015 Jan; 49(1):69-85. PubMed ID: 25352037
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and genotypic study of biofilm formation in Enterococci isolated from urinary tract infections.
Fallah F; Yousefi M; Pourmand MR; Hashemi A; Nazari Alam A; Afshar D
Microb Pathog; 2017 Jul; 108():85-90. PubMed ID: 28483600
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of vancomycin-resistant enterococcal infections].
Lund LC; Holzknecht BJ; Justesen US
Ugeskr Laeger; 2018 Apr; 180(16):. PubMed ID: 29690991
[TBL] [Abstract][Full Text] [Related]
7. Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-Resistant Enterococcus faecium Isolates in an
Belley A; Lalonde-Séguin D; Arhin FF; Moeck G
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784674
[TBL] [Abstract][Full Text] [Related]
8. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.
Cunha BA; Mickail N; Eisenstein L
Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an
Belley A; Arhin FF; Moeck G
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109163
[TBL] [Abstract][Full Text] [Related]
10. Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infections.
Arias CA; Mendes RE; Stilwell MG; Jones RN; Murray BE
Clin Infect Dis; 2012 Apr; 54 Suppl 3(Suppl 3):S233-8. PubMed ID: 22431854
[TBL] [Abstract][Full Text] [Related]
11. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
12. Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci.
Hayakawa K; Martin ET; Gudur UM; Marchaim D; Dalle D; Alshabani K; Muppavarapu KS; Jaydev F; Bathina P; Sundaragiri PR; Rajuri SD; Khatri J; Pogue JM; Lephart PR; Rybak MJ; Kaye KS
Antimicrob Agents Chemother; 2014 Jul; 58(7):3968-75. PubMed ID: 24798267
[TBL] [Abstract][Full Text] [Related]
13. Approaches to vancomycin-resistant enterococci.
Torres-Viera C; Dembry LM
Curr Opin Infect Dis; 2004 Dec; 17(6):541-7. PubMed ID: 15640708
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
Barber KE; Smith JR; Raut A; Rybak MJ
J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of Nitrofurantoin and Fosfomycin Against Outpatient Urinary Isolates of Multidrug-Resistant Enterococci over a Period of 10 Years from India.
Das A; Banerjee T; Anupurba S
Microb Drug Resist; 2020 Dec; 26(12):1509-1515. PubMed ID: 31794690
[TBL] [Abstract][Full Text] [Related]
16. Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
Tamma PD; Hsu AJ
Curr Opin Infect Dis; 2014 Dec; 27(6):517-27. PubMed ID: 25313503
[TBL] [Abstract][Full Text] [Related]
17. Phenotypes and genotypes of vancomycin-resistant enterococci isolated during long-term follow-up in a patient with recurrent bacteremia and colonization.
Yeh KM; Lu JJ; Siu LK; Peng MY; Chang FY
J Microbiol Immunol Infect; 2002 Dec; 35(4):243-8. PubMed ID: 12542250
[TBL] [Abstract][Full Text] [Related]
18. Optimizing therapy for vancomycin-resistant enterococci (VRE).
Linden PK
Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic options for vancomycin-resistant enterococcal bacteremia.
Barber KE; King ST; Stover KR; Pogue JM
Expert Rev Anti Infect Ther; 2015 Mar; 13(3):363-77. PubMed ID: 25661903
[TBL] [Abstract][Full Text] [Related]
20. Daptomycin: A viable therapeutic option for vancomycin-resistant enterococcal urinary-tract infections in Indian medical settings?
Mohan B; Garg S; Appannanavar SB; Taneja N
Indian J Med Microbiol; 2016; 34(3):398-9. PubMed ID: 27514977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
